Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-13-003424
Filing Date
2013-01-18
Accepted
2013-01-18 16:20:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 a12-29890_1424b3.htm 424B3 4035665
2 GRAPHIC g298901hoi001.gif GRAPHIC 2501
  Complete submission text file 0001104659-13-003424.txt   4040361
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-185674 | Film No.: 13537774
SIC: 2834 Pharmaceutical Preparations